United States Insulin Pens Market Research Report 2025-2033, Advances in Technology, Favorable Reimbursement Policies, Increasing Awareness and Adoption

The U.S. insulin pen market is set to grow from USD 4.2 billion in 2024 to USD 8.1 billion by 2033 at a 6.9% CAGR. Key growth drivers include advanced technology, increased awareness, and favorable reimbursement policies. Major players: Eli Lilly, Sanofi, Glooko, Medtronic, Novo Nordisk, Owen Mumford. U.S. Insulin Pens Market U.S. Insulin Pens Market Dublin, June 25, 2025 (GLOBE NEWSWIRE) — The “United States Insulin Pens Market Size, Insights, Competitive Landscape, and Forecast, 2025 – 2033”